World First Development of an Arsenic-Peptide to Target Cancer
WOLLONGONG, NSW, Australia, Apr. 12, 2019/Medianet-International-AsiaNet/-- Australian pharmaceutical firm, Phebra, has announced acollaborationand licensing agreement with the University of Wollongong (UOW) to continue development of newly patented arsenic compounds that potentially treat haematologic malignancies an...
Authors: LATEST ASIANET NEWS RELEASES